In any case, IRC117539 is a remarkable compound that induces selective death of AR-dependent prostate cancer cells regardless of their androgen sensitivity, and may especially be clinically relevant for certain cases of CRPC. The gene discussed is AR; the disease is Familial prostate cancer.